Overall, the impaired ability of CD8+ cells to engage with CK deficient lymphoma cells may represent a form of aberrant super-enhancer mediated immune evasion, which likely contribute to accelerated pathogenesis, and have implications for improving the efficacy of T cell directed immunotherapies. This evidence concerns the gene CD8A and lymphoma.